CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for IP Group Plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

IP Group Plc
2nd Floor 3 Pancras Square, Kings Cross
Phone: +44 2074440050p:+44 2074440050 LONDON, N1C 4AG  United Kingdom Ticker: IPOIPO
Business Summary
IP Group plc is a United Kingdom-based early-stage science investor. The Company develops and supports businesses in deep technology (deep tech), life sciences and clean technology (cleantech) (under its Kiko Ventures brand). In deep tech, its focus areas include applied AI, (particularly cyber security) next generation networks, human-machine interfaces and future compute. In cleantech, it targets innovators creating scalable climate technology solutions, with focus areas that include renewable electricity and alternative fuels, mobility and transport, greenhouse gas capture/removal and storage, climate risk and change management, and sustainable food and agriculture. The Company, including through funds managed by Parkwalk Advisors Limited, the United Kingdom growth EIS fund manager, backs innovation from universities and research institutions. Its portfolio includes Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
6799 Investors, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Douglas J.Flint 69 11/1/2018 9/17/2018
Chief Executive Officer, Executive Director GregSmith 44 10/6/2021 6/2/2011
Chief Financial Officer, Chief Operating Officer, Executive Director David G.Baynes 60 10/6/2021 3/1/2014
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Cell Medica Limited 27 Fitzroy Square London United Kingdom
Touchstone Innovations Ltd The Walbrook Building, 25 Walbrook LONDON United Kingdom
Delenex Therapeutics AG Wagistrasse 23 Zürich-Schlieren Switzerland
Fusion IP plc The Sheffield Bioincubator SHEFFIELD ENG United Kingdom

Business Names
Business Name
Asterion Limited
Biofusion Licensing (Sheffield) Limited
Extraject Technologies Limited
53 additional Business Names available in full report.

General Information
Number of Employees: 95 (As of 12/31/2023)
Outstanding Shares: 968,538,125 (As of 1/29/2025)
Shareholders: 991
Stock Exchange: LON
Fax Number: +44 2079296415


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, January 31, 2025